Topics
Low-grade gliomas | Treatment | Chemotherapy | Overview
Home > Publications > Topics > Low-grade gliomas > Treatment > Chemotherapy > Overview
Lassaletta A, Zapotocky M, Bouffet E.
Chemotherapy
in pediatric low-grade gliomas (PLGG).
Childs
Nerv Syst. 2024 May 31. doi:
10.1007/s00381-024-06458-w. PMID:
38819670. Review˰ ˍ
*Kinslow CJ, Roy S, Iwamoto FM, Brown PD, DeStephano DM, Canoll
PD, Qureshi SS, Gallito M, Sisti MB, Bruce JN, Horowitz DP,
Kachnic LA, Neugut AI, Yu JB, Mehta MP, Cheng SK, Wang TJC.
The
IDH paradox: Meta-analysis of alkylating chemotherapy in
IDH-wildtype and -mutant lower grade gliomas.
Neuro
Oncol. 2024 Jun 29:noae102. doi:
10.1093/neuonc/noae102. PMID:
38943513. Meta-analysis˰
ˍ
Ziu M, Halasz LM, Kumthekar PU, McGranahan TM, Lo SS, Olson JJ.
Congress of Neurological Surgeons
systematic review and evidence-based guidelines for the role of
chemotherapy in newly diagnosed WHO Grade II diffuse glioma in
adults: update.
J
Neurooncol. 2024 Nov 20. doi:
10.1007/s11060-024-04861-6. PMID:
39565459. Review; Guidelines˰
ˍ